Resources

Explore Panalgo thought leadership, white papers and booklets, case studies, webinars, videos, and more.

Filter by Topic

ICPE All Access Publications

Publication
September 16, 2020

Podium and posters at ICPE All Access Virtual Meeting, September 16-17, 2020.

Panalgo Brings the Power of Machine-Learning to the Healthcare Industry Via Its Instant Health Data (IHD) Software

Press Releases
September 15, 2020

Panalgo’s new Data Science module seamlessly integrates machine-learning techniques to identify new insights for patient care

Panalgo to Present at ICPE 2020

News & Events
September 2, 2020

ICPE All Access: 35 Years of Real-World Science September 16-17, 2020

5 Steps To Prepare For A Third-Party Drug Price Evaluation

Articles
September 1, 2020

Life Science Leader article from VP of Modeling & Evidence, Matt Sussman.

Do Research Groups Align on an Intervention’s Value? Concordance of Cost-Effectiveness Findings Between the Institute for Clinical and Economic Review and Other Health System Stakeholders

Publication
August 20, 2020

Authors: Matthew Sussman, Jeffrey C Yu, Joseph Menzin Published: Applied Health Economics Health Policy Click here to view the article.

BHE is Now Panalgo: Why We Changed Our Name and Brand

Blogs
July 27, 2020

By Joe Menzin, PhD

BHE Announces Rebrand to Panalgo, Continues Its Mission of Leadership in Analytics Software for Healthcare [Press Release]

Press Releases
July 27, 2020

Panalgo, which conveys “an algorithm for everything,” aligns with company vision of streamlining analytics, enabling pharma, payers, and providers to make more impactful decisions

Worries and Hopes for Healthcare Delivery in 2024

December 5, 2023

Industry experts from Norstella – a family of brands that includes, Citeline, the Dedham Group, Evaluate, MMIT, and Panalgo, and whose data and technologies support

Building Effective Real World Evidence Studies to Support New Indications for Established Products

December 5, 2023

In this article from PharmExec.com, Panalgo’s Executive Director of Solutions Meg Richards, and Dr. Samy Suissa, Founder of the Canadian Network for Observational Drug Effect

Leaning Into RWE: The IRA is Here, So Now’s the Time

November 28, 2023

Manufacturers are continuing to wrestle with the effects of the Inflation Reduction Act (IRA) on their business plans and revenue streams. Although some of the

Conclusions from Copenhagen: Highlights of ISPOR EU 2023

November 21, 2023

ISPOR Europe 2023, with the largest number of delegates on record (5,600) was held in wonderful, wonderful Copenhagen (cue the Danny Kaye waltz) last week.

How RWE Improves Evidence Generation Across the Product Life Cycle

November 16, 2023

Real-world evidence (RWE) is crucial for biopharmaceutical companies and other life sciences organizations to develop the right products for the marketplace. RWE is a powerful

Linking Real-World Data is Like Making a Fine, Blended Wine

November 1, 2023

In the healthcare and life sciences industries, developments like the explosion of real-world data, new regulatory programs and frameworks, and a focus on AI and

IHD Analytics

Put reliable, rapid analytics in the hands of more people across your organization

Learn more about Panalgo

Get the story behind our work and our team.